FDA authorizes Abbott’s BinaxNOW rapid test for home use
Abbott has received FDA emergency use authorization for at-home use of its BinaxNOW rapid test, which it says can deliver “results in minutes.”
The credit card-sized $25 test -- the lowest available price for at-home testing -- will become highly available in 2021, Abbott said.
Until now, the test (which requires a prescription) was available in limited quantities and needed to be performed by a trained medical professional.
Thirty million tests should be available in the first quarter of 2021 and another 90 million in the second quarter.
ABC News’ Eric Strauss contributed to this report.







